Cryoport logo
CYRXCryoport
Trade CYRX now
Cryoport primary media

About Cryoport

Cryoport (NASDAQ:CYRX) specializes in providing comprehensive cryogenic logistics solutions to the life sciences industry, ensuring the safe and efficient transport of biological materials at ultra-low temperatures. Its services are critical in supporting regenerative medicine, including the clinical research, biopharming, and reproductive medicine sectors. Cryoport's portfolio includes advanced logistics solutions, Cryoport Express® shippers, Smartpak II® Condition Monitoring System, and Cryoportal® Logistics Management Platform, designed to meet the complex logistics requirements of biopharmaceuticals, including cell and gene therapies. The company is committed to enhancing and expanding its services to support the growing needs of the life sciences community, aiming for unparalleled reliability and compliance in global logistics.

What is CYRX known for?

Snapshot

Public US
Ownership
1990
Year founded
269
Employees
Brentwood, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Cryoport

  • Temperature-controlled logistics solutions for life sciences, including biopharma and animal health.
  • Cryoport Express shippers, providing validated, temperature-controlled transportation.
  • SmartPak II Condition Monitoring System, tracking the condition of biological materials in real-time.
  • Cryoportal Logistics Management Platform, a comprehensive logistics solution for managing the transportation of life sciences commodities.
  • Biostorage services, offering secure, temperature-controlled storage for biological materials.
  • Global logistics centers, strategically located to support life sciences logistics worldwide.

equipe executiva do Cryoport

  • Mr. Jerrell W. SheltonChairman, President & CEO
  • Mr. Robert S. Stefanovich MSSenior VP, CFO, Treasurer & Chief Administrative Officer
  • Mr. Edward J. ZecchiniSenior VP and Chief Digital & Technology Officer
  • Dr. Mark W. Sawicki Ph.D.Senior VP & Chief Scientific Officer
  • Mr. Thomas J. HeinzenVice President of Corporate Development & Investor Relations
  • Mr. Tony IppolitoVP, General Counsel & Corporate Secretary
  • Ms. Kylie A. CroweVice President of Global Human Resources & Organizational Development
  • Mr. Phil WilsonChief Operating Officer of Cryoport Systems, LLC

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.